Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiujun Cai

Showing results (171-180 of 299) with videos related to

Pageof 30
Sort By:
Chemical Communications (Cambridge, England)|March 19, 2020
Zinc sulfide nanoparticle-decorated fibre mesh to enable localized H<sub>2</sub>S-amplified chemotherapyGang Wang, Dong Cen, Zhaohui Ren, et al.
International Journal of Cancer|September 27, 2016
Sorafenib with ASC-J9<sup>®</sup> synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signalsJunjie Xu, Hui Lin, Gonghui Li, et al.
Biomaterials|August 18, 2019
Bismuth embedded silica nanoparticles loaded with autophagy suppressant to promote photothermal therapyTong Chen, Dong Cen, Zhaohui Ren, et al.
Cell Death & Disease|October 13, 2017
Increasing AR by HIF-2α inhibitor (PT-2385) overcomes the side-effects of sorafenib by suppressing hepatocellular carcinoma invasion via alteration of pSTAT3, pAKT and pERK signalsJunjie Xu, Longbo Zheng, Jiang Chen, et al.
Oncotarget|January 28, 2017
DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancerJiliang Shen, Senjun Zhou, Liang Shi, et al.
Surgical Innovation|July 11, 2017
The ALPPS in the Treatment of Hepatitis B-Related Hepatocellular Carcinoma With Cirrhosis: A Single-Center Study and Literature ReviewXiujun Cai, Yifan Tong, Hong Yu, et al.
Journal of Hematology & Oncology|September 29, 2021
Targeting mutant p53 for cancer therapy: direct and indirect strategiesJiahao Hu, Jiasheng Cao, Win Topatana, et al.
Drug Design, Development and Therapy|November 4, 2015
Adenoviral delivery of truncated MMP-8 fused with the hepatocyte growth factor mutant 1K1 ameliorates liver cirrhosis and promotes hepatocyte proliferationJinghua Liu, Jianbo Li, Weiwei Fu, et al.
International Journal of Biological Sciences|October 2, 2023
cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequenceYeLing Ruan, TianYi Chen, LongBo Zheng, et al.
Frontiers in Oncology|November 15, 2021
Comparison of Outcomes After Primary Laparoscopic Versus Open Approach for T1b/T2 Gallbladder CancerJiasheng Cao, Yong Wang, Bin Zhang, et al.
Pageof 30

Showing results (171-180 of 299) with videos related to

Sort By:
Pageof 30
Chemical Communications (Cambridge, England)|March 19, 2020
Zinc sulfide nanoparticle-decorated fibre mesh to enable localized H<sub>2</sub>S-amplified chemotherapyGang Wang, Dong Cen, Zhaohui Ren, et al.
International Journal of Cancer|September 27, 2016
Sorafenib with ASC-J9<sup>®</sup> synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signalsJunjie Xu, Hui Lin, Gonghui Li, et al.
Biomaterials|August 18, 2019
Bismuth embedded silica nanoparticles loaded with autophagy suppressant to promote photothermal therapyTong Chen, Dong Cen, Zhaohui Ren, et al.
Cell Death & Disease|October 13, 2017
Increasing AR by HIF-2α inhibitor (PT-2385) overcomes the side-effects of sorafenib by suppressing hepatocellular carcinoma invasion via alteration of pSTAT3, pAKT and pERK signalsJunjie Xu, Longbo Zheng, Jiang Chen, et al.
Oncotarget|January 28, 2017
DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancerJiliang Shen, Senjun Zhou, Liang Shi, et al.
Surgical Innovation|July 11, 2017
The ALPPS in the Treatment of Hepatitis B-Related Hepatocellular Carcinoma With Cirrhosis: A Single-Center Study and Literature ReviewXiujun Cai, Yifan Tong, Hong Yu, et al.
Journal of Hematology & Oncology|September 29, 2021
Targeting mutant p53 for cancer therapy: direct and indirect strategiesJiahao Hu, Jiasheng Cao, Win Topatana, et al.
Drug Design, Development and Therapy|November 4, 2015
Adenoviral delivery of truncated MMP-8 fused with the hepatocyte growth factor mutant 1K1 ameliorates liver cirrhosis and promotes hepatocyte proliferationJinghua Liu, Jianbo Li, Weiwei Fu, et al.
International Journal of Biological Sciences|October 2, 2023
cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequenceYeLing Ruan, TianYi Chen, LongBo Zheng, et al.
Frontiers in Oncology|November 15, 2021
Comparison of Outcomes After Primary Laparoscopic Versus Open Approach for T1b/T2 Gallbladder CancerJiasheng Cao, Yong Wang, Bin Zhang, et al.
Pageof 30